Shareholders' Equity - Narrative (Details) - USD ($) $ / shares in Units, shares in Millions |
1 Months Ended | 3 Months Ended | 9 Months Ended | 174 Months Ended | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 09, 2026 |
Jun. 30, 2026 |
Feb. 28, 2022 |
Nov. 30, 2020 |
Jun. 30, 2017 |
Nov. 30, 2014 |
Sep. 30, 2026 |
Jun. 30, 2026 |
Mar. 31, 2026 |
Sep. 30, 2025 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Apr. 30, 2012 |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||||||||||||||
| Share repurchase authorization amount | $ 35,000,000,000.0 | $ 35,000,000,000.0 | $ 35,000,000,000.0 | $ 5,000,000,000.0 | ||||||||||||
| Share repurchase authorization amount, increase during period | $ 7,500,000,000 | $ 7,500,000,000 | $ 5,000,000,000.0 | $ 5,000,000,000.0 | $ 5,000,000,000.0 | |||||||||||
| Share repurchase, remaining authorized repurchase amount | $ 7,700,000,000 | $ 7,700,000,000 | $ 7,700,000,000 | |||||||||||||
| Shares repurchased (in shares) | 178.3 | |||||||||||||||
| Total cost of shares purchased | $ 600,000,000 | $ 500,000,000 | $ 250,000,000 | $ 250,000,000 | $ 250,000,000 | $ 27,300,000,000 | ||||||||||
| Antidilutive securities excluded from computation of earnings per share (in shares) | 0.1 | 0.0 | 0.5 | 0.0 | ||||||||||||
| Subsequent Event | ||||||||||||||||
| Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||||||||||||||
| Dividends payable (in dollars per share) | $ 0.820 | |||||||||||||||
| X | ||||||||||
- Definition Stock Repurchase Program, Authorized Amount, Increase During Period No definition available.
|
| X | ||||||||||
- Definition Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate dividends declared during the period for each share of common stock outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount remaining authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of shares that have been repurchased and retired during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|